Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00199875Phase 1Completed
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250
Kidney CancerKidney NeoplasmRenal Cancer+1 more
PrincipalinvestigatorStart date: 2005-07-06
NCT01774071Phase 1/2Completed
Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer
Prostate Cancer
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Memorial Sloan Kettering Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joseph O'Donoghue, PhD

Memorial Sloan Kettering Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Cancer of KidneyKidney NeoplasmsCarcinoma, Renal Cell

Worked with same sponsors:

Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center
Collaborated on 1 trial
Similarity Score34%

Neeta Pandit-Taskar, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
8 trials

Shared therapeutic areas:

Cancer of KidneyKidney NeoplasmsCarcinoma, Renal Cell

Worked with same sponsors:

Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center
Collaborated on 1 trial
Similarity Score34%

Robert Motzer, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Cancer of KidneyKidney NeoplasmsCarcinoma, Renal Cell

Worked with same sponsors:

Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center
Collaborated on 1 trial
Similarity Score34%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Prostate CancerCarcinoma, Renal Cell
Similarity Score15%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney

Worked with same sponsors:

Genentech, Inc.
Similarity Score15%

howard Safran, MD

Brown University

Related
16 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney
Similarity Score15%

Lorenzo Cohen, PhD

M.D. Anderson Cancer Center

Related
17 trials

Shared therapeutic areas:

Cancer of KidneyProstate Cancer
Similarity Score15%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney
Similarity Score15%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Carcinoma, Renal CellCancer of Kidney
Similarity Score15%

Primo N. Lara, MD

University of California, Davis

Related
13 trials

Shared therapeutic areas:

Prostate CancerCancer of Kidney

Worked with same sponsors:

Genentech, Inc.
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00199875Phase 1PrincipalInvestigator

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Kidney CancerKidney NeoplasmRenal Cancer+1 more
Completed
NCT01774071Phase 1/2PrincipalInvestigator

Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer

Prostate Cancer
Completed

All 2 trials loaded